Form 4 for GDRX GoodRx Holdings, Inc.

Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-08 · accession 0001809519-25-000145 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2025-11-10	2025-11-08	GDRX	Bruehlman Ronald E	Dir	M - OptEx	—	+21.7K	111.0K	+24%	—
D	2025-11-10	2025-11-08	GDRX	Bruehlman Ronald E	Dir	M - OptEx	$0.00	-21.7K	43.4K	-33%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2025-11-08	M	A	21,691	—	111,025	D	—	—	(F1) The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors). (F2) Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
2	Derivative	Deferred Stock Unit	2025-11-08	M	D	21,691	$0.00	43,384	D	— · — to —	21,691 Class A Common Stock	(F2) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F1) The deferred stock unit award vested as to one-third of the shares underlying the award on November 8, 2025. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2029; (ii) Separation from Service; (iii) a Change in Control; (iv) death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).